Nystatin (Fungicidin): Polyene Antifungal Agent for Candida and Model Fungal Research

Executive Summary: Nystatin (Fungicidin) is a polyene antifungal antibiotic that binds ergosterol and disrupts fungal cell membranes, leading to cell death (APExBIO). It exhibits low minimal inhibitory concentrations (MIC90 ≈ 4 mg/L) against Candida albicans and is active against multiple Candida species (0.39–3.12 μg/mL) under standardized in vitro conditions. Liposomal Nystatin protects neutropenic mice from Aspergillus infections at doses as low as 2 mg/kg/day. In Drosophila S2 cell models, Nystatin does not block S. eriocheiris entry, clarifying its selectivity for ergosterol-rich membranes (Wei et al., 2019). APExBIO’s Nystatin (B1993) is validated for reproducibility and workflow integration in antifungal research.

Biological Rationale

Nystatin, also known as Fungicidin, is a polyene macrolide antifungal discovered for its effectiveness against yeast and mycoplasma. The compound is structurally characterized by a conjugated heptaene ring, facilitating its specific interaction with ergosterol, a sterol unique to fungal cell membranes (see this mechanistic overview). This selectivity enables Nystatin to target fungal pathogens while sparing mammalian cells, which lack ergosterol and instead contain cholesterol in their membranes. The clinical and laboratory importance of Nystatin stems from its broad-spectrum activity against pathogenic Candida spp., including C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, and C. krusei (APExBIO).

Nystatin is highly valued as a research tool for characterizing antifungal susceptibility, fungal adhesion, and resistance mechanisms. It is also routinely included in cell culture protocols to suppress adventitious fungal or mycoplasmal contamination (contrasted: this article emphasizes workflow reproducibility for antifungal assays; the present article updates mechanistic scope and animal model evidence).

Mechanism of Action of Nystatin (Fungicidin)

Nystatin exerts its antifungal effect by binding directly to ergosterol within the fungal cell membrane. This interaction forms transmembrane pores, resulting in increased membrane permeability. The resulting ionic imbalance leads to leakage of vital intracellular components and ultimately cell lysis and death (see biological rationale extension).

The antifungal spectrum of Nystatin is defined by the ergosterol content of the target organism. Organisms lacking ergosterol, such as most bacteria and mammalian cells, are intrinsically resistant. Notably, in a Drosophila S2 cell infection model, Nystatin did not inhibit entry of Spiroplasma eriocheiris, confirming the requirement for ergosterol in its antifungal mechanism (Wei et al., 2019).

Nystatin does not inhibit caveola-mediated endocytosis or pathways that do not rely on ergosterol-rich domains. This selectivity is crucial for its safety profile in laboratory and clinical applications.

Evidence & Benchmarks

• MIC90 values for Nystatin against Candida albicans are approximately 4 mg/L, with effective ranges for non-albicans Candida species between 0.39–3.12 μg/mL (APExBIO product data, link).
• Liposomal Nystatin shows in vivo protection in neutropenic mice against Aspergillus infection at doses as low as 2 mg/kg/day (animal model, referenced in product literature).
• Nystatin significantly reduces adhesion of Candida species to human buccal epithelial cells, with a stronger effect on non-albicans species than on C. albicans (controlled cell adhesion assays, APExBIO).
• In Drosophila S2 cell models, Nystatin does not inhibit entry of Spiroplasma eriocheiris, confirming selectivity for ergosterol-containing membranes (Wei et al., 2019).
• Nystatin is insoluble in water and ethanol, but soluble in DMSO at ≥30.45 mg/mL; optimal storage is at -20°C (physicochemical profiling, APExBIO).

Applications, Limits & Misconceptions

Nystatin (Fungicidin) is predominantly used in laboratory research to study antifungal activity, susceptibility testing, and the mechanisms of fungal adhesion and resistance. Its applications extend to the evaluation of antifungal efficacy in animal models, particularly for Candida and Aspergillus infections. The compound is also valuable in cell culture as an agent against fungal contamination.

Recent data clarify that Nystatin’s activity is limited to ergosterol-containing membranes. It is ineffective against bacteria, viruses, and eukaryotic pathogens lacking ergosterol. For example, Spiroplasma eriocheiris infects Drosophila S2 cells via clathrin-mediated endocytosis and macropinocytosis, processes not affected by Nystatin treatment (Wei et al., 2019). This finding underscores the necessity of matching antifungal agents to the molecular biology of the target organism.

This article extends the scenario-driven focus of this data-driven workflow guide by providing in-depth evidence on Nystatin’s selectivity and application boundaries in model systems.

Common Pitfalls or Misconceptions

• Nystatin is not effective against bacteria or viruses: Its mechanism requires ergosterol, absent in these organisms.
• Nystatin does not inhibit caveola-mediated or cholesterol-rich endocytosis: It fails to block non-ergosterol-dependent entry pathways (Wei et al., 2019).
• Stock solutions are unstable at room temperature: Solutions should be stored below -20°C and used promptly after preparation (APExBIO).
• Nystatin is not suitable for long-term storage in solution: Precipitation and potency loss may occur over time.
• Application to non-fungal pathogens is unsupported: Activity is well-documented only for fungi and select mycoplasma species.

Workflow Integration & Parameters

Nystatin (Fungicidin) from APExBIO (SKU: B1993) is supplied as a solid with a molecular weight of 926.09 Da and chemical formula C₄₇H₇₅NO₁₇. It is recommended to dissolve the compound in DMSO to a concentration of ≥30.45 mg/mL using brief warming and ultrasonic agitation (product page). The solution should be stored below -20°C for several months; however, use soon after preparation is advised to maintain potency.

For antifungal susceptibility assays, MIC testing against Candida spp. should be performed using standardized broth microdilution protocols, ensuring accurate concentration and exposure times. When investigating fungal adhesion, epithelial cell models and controlled treatment durations yield reproducible results. In animal models, liposomal Nystatin has been validated at 2 mg/kg/day for protection against Aspergillus in neutropenic mice.

For further guidance on integrating Nystatin into advanced antifungal screening and resistance research, see this recent mechanistic update, which incorporates endocytosis findings and resistance dynamics. The current article expands on in vivo efficacy and selectivity evidence.

Conclusion & Outlook

Nystatin (Fungicidin) remains a cornerstone polyene antifungal agent in laboratory research, owing to its robust, ergosterol-dependent mechanism and well-quantified efficacy against Candida species. APExBIO’s Nystatin (B1993) offers validated physicochemical profiles, reproducible antifungal activity, and clear application boundaries. Recent findings confirm that its activity is limited to ergosterol-containing pathogens, with no effect on bacterial or viral entry mechanisms. Ongoing research should focus on optimizing formulations (e.g., liposomal delivery) and extending quantitative benchmarks for emerging fungal pathogens and resistance phenotypes.